C4 Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
C4 Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • C4 Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 563 %, a 14% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 563 -91.8 -14% Sep 30, 2024
Q2 2024 576 -80.7 -12.3% Jun 30, 2024
Q1 2024 595 -95 -13.8% Mar 31, 2024
Q4 2023 652 -22.5 -3.34% Dec 31, 2023
Q3 2023 655 -15.9 -2.37% Sep 30, 2023
Q2 2023 657 -47 -6.67% Jun 30, 2023
Q1 2023 690 -105 -13.2% Mar 31, 2023
Q4 2022 675 -171 -20.2% Dec 31, 2022
Q3 2022 671 -243 -26.6% Sep 30, 2022
Q2 2022 704 -135 -16.1% Jun 30, 2022
Q1 2022 795 Mar 31, 2022
Q4 2021 846 Dec 31, 2021
Q3 2021 914 Sep 30, 2021
Q2 2021 839 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.